miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma

[1]  Liang Zhou,et al.  MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment , 2014, Technology in cancer research & treatment.

[2]  C. Larsson,et al.  MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma , 2013, The Journal of investigative dermatology.

[3]  U. Wollina,et al.  Merkelzellkarzinom: eine Überprüfung und Aktualisierung über die Pathogenese, Diagnose und Therapieansätze , 2013, Wiener Medizinische Wochenschrift.

[4]  Jingwei Cheng,et al.  Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. , 2012, The Journal of clinical investigation.

[5]  James T. Elder,et al.  Distinct gene expression profiles of viral- and non-viral associated Merkel cell carcinoma revealed by transcriptome analysis , 2012, The Journal of investigative dermatology.

[6]  C. Haglund,et al.  BMI1 expression identifies subtypes of Merkel cell carcinoma , 2012, Virchows Archiv.

[7]  C. Haglund,et al.  Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus , 2012, Virchows Archiv.

[8]  C. Haglund,et al.  Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases. , 2012, European journal of cancer.

[9]  Sakari Knuutila,et al.  MicroRNA profiling differentiates colorectal cancer according to KRAS status , 2012, Genes, chromosomes & cancer.

[10]  H. Joensuu,et al.  Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR‐alpha and survival in Merkel cell carcinoma , 2011, International journal of cancer.

[11]  H. Joensuu,et al.  Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma , 2011, Clinical Cancer Research.

[12]  J. Schelter,et al.  Myc overexpression brings out unexpected antiapoptotic effects of miR-34a , 2011, Oncogene.

[13]  K. Hayashi,et al.  Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. , 2011, Human pathology.

[14]  J. Califano,et al.  Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission , 2010, International journal of cancer.

[15]  J. Goedert,et al.  Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression , 2010, International journal of cancer.

[16]  J. Molès,et al.  Merkel Cell Polyomavirus in Cutaneous Swabs , 2010, Emerging infectious diseases.

[17]  J. Goedert,et al.  Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome , 2009, International journal of cancer.

[18]  H. Joensuu,et al.  Incidence of Merkel cell carcinoma in renal transplant recipients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  S. Swerdlow,et al.  Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors , 2009, International journal of cancer.

[20]  H. Joensuu,et al.  Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma , 2009, British Journal of Cancer.

[21]  H. Joensuu,et al.  Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. , 2009, Journal of the National Cancer Institute.

[22]  L. Chin,et al.  Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. , 2009, The Journal of investigative dermatology.

[23]  J. Rader,et al.  Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. , 2009, RNA.

[24]  M. Yamakuchi,et al.  MiR-34, SIRT1, and p53: The feedback loop , 2009, Cell cycle.

[25]  Yuan Chang,et al.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus , 2008, Proceedings of the National Academy of Sciences.

[26]  M. Yamakuchi,et al.  miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.

[27]  P. Moore,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.

[28]  Gregory J. Hannon,et al.  microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.

[29]  Moshe Oren,et al.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.

[30]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[31]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[32]  J. Cardoso,et al.  Merkel cell carcinoma: a review and update on aetiopathogenesis, diagnosis and treatment approaches. , 2013, Wiener medizinische Wochenschrift.

[33]  J. Q. Rosso,et al.  Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients , 2010 .

[34]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.